Serum Institute of India
Indian biotechnological company, vaccine manufacturer
Serum Institute of India ▸ Facts ▸ Comments ▸ News ▸ Videos
Covid vaccine: How many Indians got jab on Day 1? Govt reveals
Credit: HT Digital Content Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience
Credit: HT Digital Content Duration: 08:15Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India
Credit: ANI Duration: 02:39Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine
Credit: ANI Duration: 01:08Published
COVID-19 vaccination drive begins in India
Credit: ANI Duration: 01:41Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive
Credit: HT Digital Content Duration: 03:02Published
COVID vaccine reaches length and breadth of country
Credit: ANI Duration: 02:57Published
Over 3 lakh Covisheild doses reach Raipur
Credit: ANI Duration: 01:37Published
Jammu, Kanpur receive Covisheild vaccine
Credit: ANI Duration: 02:01Published
Covisheild vaccine reaches Kochi
Credit: ANI Duration: 01:39Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch
Credit: HT Digital Content Duration: 02:39Published
5.06 lakh doses of Covishield vaccine arrives at Bhopal airport
Credit: ANI Duration: 01:41Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield
Credit: HT Digital Content Duration: 02:02Published
First batch of 'Covishield' arrives in Mumbai
Credit: ANI Duration: 01:21Published
You Might Like
India may get four more COVID-19 vaccines soon, SII says work in progressAccording to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
India plans 20 million doses of vaccine supply to neighboursIndia plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian..
Serum Institute expects WHO emergency approval for AstraZeneca shot soonThe Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief..
Experts question govt vaccine purchase price, say it’s higherAs the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s..
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
J&K receives 1.46 lakh doses of coronavirus vaccineJammu and Kashmir on Wednesday received the first consignment of 1.46 lakh doses of coronavirus vaccine from Pune-based Serum Institute of India (SII), officials said. While 79,000 doses were received..
India’s biggest vaccine rollout begins as SII ships 55 lakh dosesDelhi, Chennai, Kolkata and Hyderabad, the four major regional depots for Covid-19 vaccines, received their quantum of Covishield doses within 10 hours since their dispatch began from the SII premises..
COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price hereSerum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000.
54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: CentreThe Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of..
Covishield dispatch for vaccine drive a historic moment: Serum Institute of India
Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla"We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare..
Government committed to buy another 4.5 crore doses of Covishield vaccineThe government has committed to buy from the Serum Institute further 4.5 crore doses of Oxford Covid-19 vaccine, Covishield, at a price of Rs 200 per shot plus applicable taxes by April, in addition to..
First Covishield vaccines consignment leaves Serum InstituteA decisive phase in India's fight against coronavirus began in the wee hours on Tuesday as the first consignment of Covishield vaccines left Serum Institute of India for Pune airport, four days ahead..
SII gets order for 11 million vaccine doses, trucks ready for transportationThe process of transporting Covishield vaccine began on Monday after the Serum Institute of India (SII) received the Centre’s initial purchase order for 11 million doses at Rs 200 per dose. This..
India wants Serum Institute to lower price of AstraZeneca shot, say sourcesThe Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme...
Vaccine transport from Serum Institute to start on Jan 11 or 12: Sources
Brazil President Jair Bolsonaro writes to PM for 2m Covishield dosesWith Covid cases in Brazil topping 8 million, its President Jair Bolsonaro wrote a letter to PM Modi this week asking for 2 million Covishield vaccines manufactured by Serum Institute. Brazil, he said,..
Serum’s vaccine despatch delayed another 48 hoursThe massive airlift of the Covishield vaccine doses from here has been delayed by another 48 hours. It is now likely to happen only by Monday. Vaccine manufacturer Serum Institute of India has..
Vaccine take-off from Pune waits for govt to place orderPune airport was ready on Thursday night to begin facilitating a massive airlift of Covid-19 vaccines, perhaps the largest such exercise in the world, but its manufacturer here, Serum Institute of..
Brazil dials India on Covid vaccine importsIndia’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of..
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccinesVaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world.
Centre taking up Covid-19 vaccination in a big way: Harsh VardhanUnion health and family welfare minister Dr Harsh Vardhan on Monday said the Centre has initiated a series of actions to prevent the spread of coronavirus and that it is now taking up the vaccination..
Like Putin and Joe Biden, PM Modi should also get the first vaccine shot, says Cong leaderThe DCGI on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Coronavirus vaccine price: SII CEO reveals how much it will costCOVID-19 vaccines of Serum Institue of India and Bharat Biotech were granted permission for restricted use in an emergency situation on Sunday.
Private hospitals, companies may get vaccine by March: Serum CEOSII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,..
Serum Institute says to meet local demand for AstraZeneca vaccine for next two months before exportingSerum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months..
WHO welcomes India's emergency use authorisation approval to COVID-19 vaccinesThe COVID-19 vaccines of the Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
'Watershed moment in India's battle against COVID': Politicos react over emergency use approvalDCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
Covishield COVID-19 vaccine ready to roll out in coming weeks: SII's Adar PoonawallaPoonawalla's remarks came soon after DCGI approved Serum Institute's 'Covishield' vaccine for restricted emergency use in India.
BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccinesThe approval comes after the clearances from the Subject Expert Committee (SEC).
Bharat Biotech’s Covaxin too gets nod for emergency useIndia's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
After Covishield, India's Covaxin gets expert panel nod for emergency useAn expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
Happy New Year: Expert panel clears Oxford vaccine for IndiaIndia moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum..
India set to approve its first Covid vaccine; nationwide dry run tomorrowA day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator's expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca..
UK approves Oxford vaccine, raising hopes for India rolloutIndia's subject expert committee that met on Wednesday sought more data relating to the vaccine's immunogenicity, which will mean the emergency-use approval may take a few more days. The committee is..
India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccineCDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's biggest vaccine producer, has already..
UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute
Expert committee to consider Serum Institute's request for emergency vaccine use
Covid-19: 40-50m shots stockpiled by SII, India to get most of itIndia will initially get most of the 40-50 million ‘Covishield’ vaccine shots stockpiled by the Serum Institute of India (SII), since exports would require the World Health Organisation’s..
Union health minister Harsh Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'Union health minister Harsh Vardhan on Monday launched the country's first pneumococcal conjugate vaccine 'Pneumosil' developed by Serum Institute of India in collaboration with partners like the Bill..
Expecting Covid vaccine approval soon; 50 million doses ready: Serum Institute CEO
Covid-19: Oxford vaccine may get nod in a few daysIndia is likely to see the Oxford-AstraZeneca vaccine being approved for emergency use in next few days as the updated data submitted by Serum Institute of India (SII) appears “satisfactory”, top..
COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar PoonawallaPoonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit
COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of IndiaSerum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization.
India requires Rs 80,000 crore for vaccine distribution next year: SIINEW DELHI: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said that the country would require a..
India may commence COVID-19 vaccination drive by Jan, normal life will resume by Oct: SII CEO Adar PoonawallaAdar Poonawala said that the government wants to procure 300-400 million doses by July 2021
Covid-19: Serum Institute of India to get India nod soon after UK approval
Covid-19: Vaccine makers asked to submit more dataThe drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and..
CDSCO expert panel seeks more data on Covid-19 vaccines from Serum Institute, Bharat BiotechAn expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates of Serum Institute and Bharat..